Covidien Ltd Launches Duet TRS(TM) Reload with Tissue Reinforcement

PHOENIX--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has launched the Duet TRS™ reload with tissue reinforcement. The product was introduced to hundreds of surgeons at the annual convention of the Society of Gastrointestinal and Endoscopic Surgeons (SAGES) in Phoenix. The device is now available in the United States and throughout the world.
MORE ON THIS TOPIC